...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Discussion Forum: Zenith Epigenetics
List Message View
Thread Message View
New Message
Message Title
Rating
Author / Date
Pfizer lays out ambitious vision for cancer portfolio in bid to reinvigorate its business.
6
narmac
Mar 01, 2024 07:09PM
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
5
narmac
Mar 01, 2024 01:25PM
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
3
fuzzyjr
Mar 01, 2024 01:23PM
Icon president Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
7
Nextblockbuster
Mar 01, 2024 12:47PM
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N

tada
Mar 01, 2024 11:55AM
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
4
narmac
Mar 01, 2024 07:04AM
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
2
fuzzyjr
Mar 01, 2024 06:43AM
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
7
tada
Feb 29, 2024 11:15PM
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
4
fuzzyjr
Feb 29, 2024 05:21PM
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
8
tada
Feb 29, 2024 02:48PM
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
4
narmac
Feb 29, 2024 11:09AM
Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
1
fuzzyjr
Feb 29, 2024 10:39AM
Re: More Exempt Distribution Investments
4
narmac
Feb 29, 2024 10:38AM
Re: More Exempt Distribution Investments
3
KOO-KOO2
Feb 28, 2024 04:51PM
Re: More Exempt Distribution Investments
1
fuzzyjr
Feb 28, 2024 04:32PM
Re: ZHCLF
8
narmac
Feb 11, 2024 07:57AM
Re: ZHCLF
6
narmac
Feb 08, 2024 10:46AM
Re: ZHCLF
4
narmac
Feb 08, 2024 06:53AM
Re: ZHCLF
3
narmac
Feb 08, 2024 06:43AM
Icon president Re: ZHCLF
4
Nextblockbuster
Feb 06, 2024 11:23AM
New Message